New study finds that cancer-causing proteins in Ewing sarcoma and prostate carcinoma prompt tumour cells to release certain RNAs to turn off the immune response

A recent study published in the Journal of Clinical Investigation found that certain cancer-causing proteins can switch on parts of a person’s genetic material that were previously inactive, potentially contributing to the development and progression of Ewing sarcoma and prostate cancer. This finding helps researchers understand why the environment around a tumour may cause inflammation and suppress the immune system, which can make it challenging to successfully treat solid tumours with immunotherapy. 

Back to top